Story

[IEP X INSIGHT] Macrophage-targeted cancer therapies Part 2.

Strategies for Reprogramming or Activating Macrophages

[IEP X INSIGHT] Macrophage-targeted cancer therapies Part 1.

About tumour-associated macrophages(TAMs)

[Process development] Mass spectrometry Part 3.

About tandem mass spectrometry(MS/MS)

[Process development] Mass spectrometry Part 2.

Types of mass analyzers of MS

[Process development] Mass spectrometry (MS) Part 1.

Principle of mass spectrometry – ionization method

[Process development] Microorganism contamination in downstream biopharmaceutical processes

Mainly about viral clearance in downstream of biopharmaceutical process

[IEP X INSIGHT] Understanding Immunotherapy for Cancer Treatment Part 4.

About cancer vaccines, and development directions of immunotherapy for cancer

[IEP X INSIGHT] Understanding Immunotherapy for Cancer Treatment Part 3.

Adoptive T cell transfer therapy (TIL, CAR-T)

[IEP X INSIGHT] Understanding Immunotherapy for Cancer Treatment Part 2.

About Immune checkpoint blockade – CTLA4 & PD1/PDL1 blockade